Medical Center Viva Phoenix OOD

At Medical Center Viva Phoenix OOD in Dobrich, cardiovascular research focuses on atherosclerotic heart and blood vessel disease and broader cardiovascular disease risk. These studies are designed to evaluate whether new treatment approaches can better reduce major heart and stroke-related events and improve long-term protection for patients.

• Atherosclerotic cardiovascular disease and prevention of major adverse cardiovascular events
• Testing a new therapy aimed at lowering the risk of heart attack, stroke, and related complications

This area reflects a strong interest in improving outcomes for people whose current lipid-lowering treatment is not enough.

The site also conducts important studies in nutritional and metabolic diseases, with a major emphasis on chronic kidney disease, albuminuria, and high proteinuria. These trials are exploring ways to slow kidney function decline, reduce kidney damage, and improve disease control in people living with chronic kidney conditions.

• Chronic kidney disease with albuminuria or high proteinuria
• Non-diabetic chronic kidney disease and progression prevention
• Evaluating new combinations and add-on treatments to protect kidney function

Research in this area aims to improve treatment effectiveness beyond standard care for patients at risk of worsening kidney disease.

Clinical trials at the center include work in metabolism and type 2 diabetes, especially studies looking at blood sugar control in adults already using basal insulin. The goal is to assess whether a newer weekly insulin approach can help simplify treatment while maintaining effective glycaemic control.

• Type 2 diabetes management and blood sugar reduction
• Comparing a weekly insulin option with standard daily insulin therapy
• Improving convenience and effectiveness in diabetes care

This research may help identify more practical ways to support people who need ongoing insulin treatment.

The clinical research portfolio also includes studies in immune system diseases, particularly Graves’ disease, an autoimmune thyroid condition. These trials are focused on evaluating a potential new treatment for restoring and maintaining normal thyroid function, with an emphasis on long-term disease control.

• Graves’ disease and thyroid hormone balance
• Testing a therapy intended to support euthyroidism and reduce dependence on standard medication
• Assessing longer-term management of autoimmune thyroid disease

This work highlights the site’s involvement in autoimmune and endocrine research aimed at improving everyday treatment outcomes for patients.